MX2009010713A - Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos. - Google Patents

Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.

Info

Publication number
MX2009010713A
MX2009010713A MX2009010713A MX2009010713A MX2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A
Authority
MX
Mexico
Prior art keywords
bone
herbal formulation
treatment
bone fractures
fractures
Prior art date
Application number
MX2009010713A
Other languages
English (en)
Spanish (es)
Inventor
Alfredo Avila
Original Assignee
Alfredo Avila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfredo Avila filed Critical Alfredo Avila
Publication of MX2009010713A publication Critical patent/MX2009010713A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
MX2009010713A 2007-04-02 2008-04-01 Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos. MX2009010713A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90745107P 2007-04-02 2007-04-02
PCT/US2008/004220 WO2008123970A1 (en) 2007-04-02 2008-04-01 Herbal formulation for the treatment of bone fractures and osseous defects

Publications (1)

Publication Number Publication Date
MX2009010713A true MX2009010713A (es) 2009-12-15

Family

ID=39794790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010713A MX2009010713A (es) 2007-04-02 2008-04-01 Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.

Country Status (4)

Country Link
US (2) US7871648B2 (enExample)
JP (1) JP5374491B2 (enExample)
MX (1) MX2009010713A (enExample)
WO (1) WO2008123970A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5860471B2 (ja) 2010-11-15 2016-02-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Ｎ−アリールピラゾール（チオ）カルボキサミド類
CN111084780A (zh) * 2020-01-09 2020-05-01 昆明医科大学 老鹳草素在制备治疗骨质疏松合并骨折的药物中的用途
RU2758135C1 (ru) * 2021-01-25 2021-10-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения больных с замедленной консолидацией переломов костей нижней трети голени

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0789862A (ja) * 1990-05-29 1995-04-04 Toyobo Co Ltd 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
GB2311009B (en) * 1996-03-06 2000-01-26 Mohd Taufiq Khan Pharmaceutical compositions containing tagetes plants
JPH10194917A (ja) * 1997-01-14 1998-07-28 Noevir Co Ltd 抗菌性低刺激化粧料
US20070020724A1 (en) * 1998-06-16 2007-01-25 Ruben Steven M 94 human secreted proteins
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
RO120121B1 (ro) * 2000-12-18 2005-09-30 Elena Ionaşcu Soluţie injectabilă, cu efect antiinflamator, procedeu de obţinere şi metodă de tratament a bolilor autoimune
JP2002193733A (ja) * 2000-12-25 2002-07-10 Kanebo Ltd 化粧料
US20030203843A1 (en) * 2001-04-20 2003-10-30 Pena Carol E. A. Proteins and nucleic acids encoding same
EP1576169B1 (en) * 2002-03-19 2016-08-10 Celldex Therapeutics, Inc. Therapeutic polypeptides and methods of use
WO2003092666A1 (en) * 2002-05-01 2003-11-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Calcium-containing tissue strengthening agents and use thereof
JP2005126327A (ja) * 2003-10-21 2005-05-19 Pola Chem Ind Inc 化粧崩れ防止化粧料
WO2006032091A2 (en) * 2004-09-21 2006-03-30 Lavender Hill Projects Pty Ltd Herbal composition

Also Published As

Publication number Publication date
US20110076345A1 (en) 2011-03-31
JP2010523563A (ja) 2010-07-15
JP5374491B2 (ja) 2013-12-25
US20080241277A1 (en) 2008-10-02
US8337910B2 (en) 2012-12-25
WO2008123970A1 (en) 2008-10-16
US7871648B2 (en) 2011-01-18

Similar Documents

Publication Publication Date Title
DOP2019000287A (es) Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi)
NI201200090A (es) Composiciones para tratar náusea y vómito centralmente mediados
DOP2012000246A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
BR112016002695A2 (pt) métodos e aparelhos para tratamento de pelo com o uso de ablação de tecido não térmica
EA201691079A1 (ru) Комбинированная терапия для лечения онкологического заболевания
CO6362005A2 (es) Compuestos de multiheteroarilo como inhibidores de prostaglandina d sintasa hematopoyetica y su uso para tratar enfermedades mediadas por prostaglandina d2
CR11731A (es) Composiciones y procedimientos para su preparación y uso
UY32359A (es) Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento
EA201790142A1 (ru) Лечение лейкоза ингибиторами гистондеацетилазы
BR112013002319A2 (pt) compostos e métodos para reparo da pele
CO6620068A2 (es) Anticuerpos monoclonales optimizados contra el inhibidor de la via del factor tisular (tfpi)
EA201591996A1 (ru) Способы и композиции для заживления раны
DOP2013000131A (es) Composiciones y métodos para tratar el cáncer usando un inhibidor de pi3k y un inhibidor de mek
UY36405A (es) Formulaciones reguladoras/bioestimulantes del crecimiento de las plantas y de los cultivos y métodos para usarlas
CL2015000886A1 (es) Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer.
MX2009010713A (es) Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.
BRPI0719885A2 (pt) Pht alquilados como moduladores de receptores de pth e usos dos mesmos27
MX2013001979A (es) Uso de paulownin y/o extractos de madera de paulownia para preparar composiciones topicas para el tratamiento de la celulitis
EA201201338A1 (ru) Способы лечения комбинированных лучевых и тепловых поражений
CU24631B1 (es) Método para inactivar xenoantígenos en tejidos biológicos
EP3996614C0 (de) Frakturfixationsplatte zur applikation am proximalen humerus
DOP2014000221A (es) Métodos para tratar el cáncer usando inhibidor de pi3k e inhibidor de mek
UA35391U (ru) Способ лазерно-хирургического удаления олигоастроцитом полушарий большого мозга с медианным распространением
DOP2017000096A (es) Uso del ácido neridrónico o de su sal para el tratamiento de la osteoartrosis

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration